Biotechnology Stocks
| # | 7 Derniers Jours | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 4116 |  OABIW OmniAb, Inc. - Warrant | 0.3900 USD | 0.00% | 0.00% | +6.12% | +160.00% | 56.70 M USD | ||
| 4119 |  INKT MiNK Therapeutics, Inc. - Common Stock | 11.00 USD | -3.68% | -12.35% | -13.32% | 0.00% | 56.13 M USD | ||
| 4120 |  GUTS Fractyl Health, Inc. - Common Stock | 4.23 USD | -6.42% | +861.36% | +531.34% | +200.00% | 56.11 M USD | ||
| 4125 |  ATHE Alterity Therapeutics Limited - American Depositary Shares | 3.07 USD | -7.53% | -9.44% | -31.17% | -27.59% | 55.65 M USD | ||
| 4126 |  CNTB Connect Biopharma Holdings Limited - American Depositary Shares | 0.88 USD | -6.38% | -10.20% | -55.78% | -56.00% | 55.42 M USD | ||
| 4139 |  LONA LeonaBio, Inc. - Common Stock | 5.75 USD | -1.37% | +32.49% | -19.47% | -14.69% | 54.17 M USD | ||
| 4141 |  ACET Adicet Bio, Inc. - Common Stock | 5.74 USD | -7.12% | -14.33% | -39.32% | +523.91% | 53.73 M USD | ||
| 4151 |  HYPD Hyperion DeFi, Inc. - Common Stock | 3.37 USD | -6.13% | -12.69% | -4.80% | -62.47% | 52.37 M USD | ||
| 4155 |  DOMH Dominari Holdings Inc. - Common Stock | 2.15 USD | -0.46% | +2.38% | +11.40% | -65.82% | 52.12 M USD | ||
| 4156 |  XLO Xilio Therapeutics, Inc. - Common Stock | 9.01 USD | 0.00% | +1.35% | +0.67% | +947.67% | 52.10 M USD | ||
| 4161 |  CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 USD | -22.58% | -61.29% | -66.20% | -82.61% | 51.46 M USD | ||
| 4168 |  SER Serina Therapeutics, Inc. Common Stock | 2.00 USD | -0.99% | +0.50% | -20.00% | +19.76% | 50.80 M USD | ||
| 4169 |  INMB INmune Bio Inc. - Common stock | 1.83 USD | -1.61% | -5.67% | -24.69% | -7.58% | 50.79 M USD | ||
| 4172 |  ANVS Annovis Bio, Inc. Common Stock | 1.18 USD | -1.67% | -0.84% | -2.48% | -27.16% | 50.28 M USD | ||
| 4178 |  CRVO CervoMed Inc. - Common Stock | 3.28 USD | +3.14% | +10.81% | +31.20% | -61.82% | 49.59 M USD | ||
| 4194 |  APLM Apollomics Inc. - Class A Ordinary Shares | 21.70 USD | +0.93% | -7.66% | -9.21% | +17.93% | 47.65 M USD | ||
| 4196 |  ELTX Elicio Therapeutics, Inc. - Common Stock | 1.81 USD | -2.16% | -7.65% | -16.59% | -81.90% | 47.57 M USD | ||
| 4199 |  CELU Celularity Inc. - Class A Common Stock | 1.46 USD | -0.68% | +2.10% | +1.39% | -32.09% | 47.38 M USD | ||
| 4203 |  IMA ImageneBio, Inc. - Common Stock | 4.12 USD | -10.63% | -10.04% | -17.93% | -49.39% | 46.77 M USD | ||
| 4211 |  TVGN Tevogen Bio Holdings Inc. - Common Stock | 7.06 USD | +8.78% | +7.13% | -2.75% | +854.05% | 45.97 M USD |
Nouvelles Biotechnology Stocks
Le médicament de Pharvaris contre l’angiœdème héréditaire soulage plus vite
Raymond James initie une couverture de Kymera Therapeutics avec une note de surperformance
Raymond James initie la couverture de Nektar avec une note Performance Marché
L’action Palisade Bio initiée à Surperformance par Raymond James
Raymond James réitère sa note sur l’action Liquidia malgré les dépôts juridiques
Tenax Therapeutics suspend temporairement le recrutement dans l’essai LEVEL-2 de TNX-103 afin de modifier les critères ; demande une réunion avec la FDA
Ginkgo Bioworks soutient le programme NSF X-Labs avec son laboratoire
Gainers Biotechnology Stocks
 GRDX GridAI Technologies Corp. - Common Stock | 4.80 | +16.50% |
 CLGN CollPlant Biotechnologies Ltd. - Ordinary Shares | 3.97 | +14.74% |
 IPSC Century Therapeutics, Inc. - Common Stock | 1.46 | +14.06% |
 ADCT ADC Therapeutics SA Common Shares | 1.59 | +11.97% |
 CDTTW CDT Equity Inc. - Warrant | 0.0117 | +11.43% |
 SRZN Surrozen, Inc. - Common Stock | 27.97 | +11.26% |
 ANL Adlai Nortye Ltd - American Depositary Shares | 15.51 | +10.39% |
 QNCX Quince Therapeutics, Inc. - Common Stock | 29.36 | +9.88% |
Losers Biotechnology Stocks
 SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0088 | -27.87% |
 YDESW YD Bio Limited - Warrants | 0.5000 | -23.08% |
CRBU Caribou Biosciences, Inc. - Common Stock | 0.48 | -22.58% |
 TCRX TScan Therapeutics, Inc. - Common Stock | 0.23 | -17.86% |
 KALA KALA BIO, Inc. - Common Stock | 0.30 | -16.67% |
 BRTX BioRestorative Therapies, Inc. - Common Stock | 1.89 | -15.62% |
 MLEC Moolec Science SA - Ordinary Shares | 4.19 | -12.89% |
 LPCN Lipocine Inc. - Common Stock | 1.93 | -12.27% |